WuXi Biologics (Cayman) Inc. (BKK:WUXI06)

WuXi Biologics Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	566,540	318,596	550,078	1,121,141	1,664,697	1,625,805
Market Cap Growth	108.44%	-42.08%	-50.94%	-32.65%	2.39%	233.20%
Enterprise Value	551,663	313,963	540,321	1,098,048	1,618,725	1,619,264
PE Ratio	29.78	20.19	33.37	50.61	93.99	209.36
PS Ratio	6.23	3.63	6.66	14.65	30.95	63.00
PB Ratio	2.55	1.49	2.58	6.18	9.74	16.92
P/TBV Ratio	2.91	1.70	2.96	6.79	10.56	17.69
P/FCF Ratio	71.03	52.62	182.37	-	-	-
P/OCF Ratio	21.84	12.99	24.31	40.37	92.82	187.95
EV/Sales Ratio	6.14	3.58	6.54	14.35	30.10	62.75
EV/EBITDA Ratio	17.69	11.42	22.61	43.22	85.50	198.82
EV/EBIT Ratio	22.42	14.56	28.34	50.36	97.69	234.41
EV/FCF Ratio	69.17	51.85	179.13	-	-	-
Debt / Equity Ratio	0.10	0.11	0.10	0.12	0.13	0.16
Debt / EBITDA Ratio	0.73	0.82	0.89	0.86	1.18	1.85
Debt / FCF Ratio	2.90	3.84	7.33	-	-	-
Asset Turnover	0.34	0.33	0.32	0.33	0.28	0.24
Inventory Turnover	6.36	6.71	5.04	4.31	3.94	4.15
Quick Ratio	2.40	1.98	2.35	1.56	1.85	2.49
Current Ratio	2.88	2.73	2.78	1.98	2.37	3.16
Return on Equity (ROE)	10.51%	8.82%	8.90%	13.20%	13.09%	10.02%
Return on Assets (ROA)	5.89%	5.05%	4.63%	5.81%	5.43%	4.03%
Return on Capital (ROIC)	6.64%	5.79%	5.51%	7.00%	6.47%	4.78%
Return on Capital Employed (ROCE)	10.60%	9.50%	8.00%	10.80%	8.90%	6.10%
Earnings Yield	3.36%	4.95%	3.00%	1.98%	1.06%	0.48%
FCF Yield	1.41%	1.90%	0.55%	-0.15%	-0.97%	-1.17%
Buyback Yield / Dilution	2.55%	2.80%	0.62%	1.04%	-5.05%	-5.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.